Autonomic Technologies, Inc. (ATI®) is a medical device company headquartered in the San Francisco Bay Area with offices in Germany, focused on the development and commercialization of innovative therapies for the treatment of autonomic disorders, particularly severe headache. The company’s initial product, the Pulsante® Microstimulator, is CE marked in Europe for the treatment of cluster headache. The device (also known as Autonomic Technologies, Inc. (ATI®) Neurostimulation System) is under an IDE study in the US for the treatment of chronic cluster headache. For more information, please visit: www.pulsante.eu or www.ati-spg.com.
Looking for a particular Autonomic Technologies employee's phone or email?
The Autonomic Technologies annual revenue was $4 million in 2026.
Benjamin Pless is the CEO of Autonomic Technologies.
11 people are employed at Autonomic Technologies.
Autonomic Technologies is based in Mountain View, California.
The NAICS codes for Autonomic Technologies are [33, 334].
The SIC codes for Autonomic Technologies are [384, 38].